Literature DB >> 4324300

Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells.

R V Blanden.   

Abstract

The following passive transfer experiments evaluated the contributions of the various host responses in recovery from mousepox. (a) Immune spleen cells transferred highly efficient antiviral activity, but preinfected recipients of these cells made no detectable splenic interferon or antibody in the 24 hr interval after cell transfer. (b) Passively administered interferon was ineffective. (c) Recipients of hyperimmune serum had much more antibody than recipients of immune spleen cells but significantly less antiviral activity. (d) Immune spleen cell populations with antiviral activity contained mediators of CMI to virus antigens. (e) The antiviral activity of immune spleen cells was specific; it was inhibited by in vitro treatment with ATS, anti-light chain serum, and anti-theta ascitic fluid, but not by removal of mononuclear phagocytes from the immune population. These results are interpreted to mean that recovery mechanisms conferred by immune spleen cells were triggered by specifically sensitized, thymus-derived lymphocytes, and that antibody and interferon responses were of less importance. A radiosensitive recipient component was necessary for the full expression of the antiviral activity of both immune cells and immune serum. It seemed likely that this component was the blood monocyte.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4324300      PMCID: PMC2138917          DOI: 10.1084/jem.133.5.1074

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice.

Authors:  T P Subrahmanyan; C A Mims
Journal:  Br J Exp Pathol       Date:  1966-04

2.  Recovery of delayed-type hypersensitivity in mice following suppressive doses of X-radiation.

Authors:  A Volkman; F M Collins
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

3.  The effect of anti-lymphocyte globulin on cell-mediated reistance to infection.

Authors:  G B Mackaness; W C Hill
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

4.  The mononuclear-cell infiltrate in allergic contact dermatitis. 2. Selective accumulation of cells from the bone marrow.

Authors:  S Lidén
Journal:  Acta Pathol Microbiol Scand       Date:  1967

5.  Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems.

Authors:  D M Lubaroff; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

6.  The origin and turnover of mononuclear cells in peritoneal exudates in rats.

Authors:  A Volkman
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

7.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

8.  Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice.

Authors:  G J Nossal; A Cunningham; G F Mitchell; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

9.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

10.  Mechanisms of acquired resistance in mouse typhoid.

Authors:  R V Blanden; G B Mackaness; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  61 in total

1.  Quantitation of immunoglobulin-bearing lymphocytes and the lymphocyte response to PHA in experimental pyelonephritis.

Authors:  T E Miller; G Simpson; D J Ormrod
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

2.  The hamster as an experimental animal for the study of influenza. II. The role of spleen cells in protection.

Authors:  R Jennings; J P Phair; M D Denton; C W Potter
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

3.  Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections.

Authors:  M B McGeorge; P S Morahan
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

5.  The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.

Authors:  L M Hutt
Journal:  J Hyg (Lond)       Date:  1975-06

6.  Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.

Authors:  Adam R Hersperger; Nicholas A Siciliano; Laurence C Eisenlohr
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

7.  Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination.

Authors:  L B Epstein; D A Stevens; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

8.  Polymorphic peptide transporters in MHC class I monomorphic Syrian hamster.

Authors:  M Lobigs; H S Rothenfluh; R V Blanden; A Müllbacher
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes.

Authors:  R Gruenewald; S Levine
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

10.  Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Authors:  Linda S Wyatt; Patricia L Earl; Leigh Anne Eller; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.